Clinical Trial Update: Dienogest Versus Luteal Phase Fluoxetine in the Management of Premenstrual Syndrome [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing dienogest to luteal-phase fluoxetine for management of Premenstrual Syndrome; status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Premenstrual Syndrome

Drugs mentioned

• Dienogest (dienogest)
• Fluoxetine (Fluoxetine)

Snippet

Sponsor: Cairo University | Conditions: Premenstrual Syndrome | Phase 3 | Status: UNKNOWN